RVRCRevium Recovery Inc.

About Revium Recovery Inc. (RVRC)

Revium Recovery Inc. (RVRC) is a Health Information Services company headquartered in Herzliya, Israel whose shares trade over-the-counter on the Pink tier.

The Company is a pre-clinical biopharmaceutical company. Following the closing of the share exchange, on July 23, 2024 with LipoVation Ltd. ("LipoVation"), and all shareholders of LipoVation, LipoVation became a wholly-owned subsidiary of the Company. The Company is focusing its business operations primarily on the development of the acquired LipoVation's business. Through LipoVation, the Company is focusing on development of innovative technologies platforms for unmet medical needs that can be implemented across a number of healthcare related fields. The Company is also currently evaluating all options to monetize its existing assets, in addition to exploring other strategic alternatives to maximize value for its stockholders. Potential strategic alternatives that may be explored or evaluated by the Company as part of this process include, but are not limited to, an acquisition, merger, reverse merger, other business combination, sale of assets, licensing or other strategic transactions involving the Company. The Company has discontinued all its prior activities and efforts with respect to the development and activation of the clinical decision-making support system (DMSS).

Products and services

The Company, through LipoVation, is focusing on developing and marketing a range of novel Nano-Liposomal Particles (NLP)-based medicines including novel formulation of a potent antibiotic that shows promise in combating several life-threatening antibiotic-resistant bacteria that have no treatment today and novel adjuvant to cancer therapies. The Company also explores the opportunity of developing a novel platform for immunization based on Liposomal Protein-Loaded Technology (LPLT). In addition, the Company is exploring opportunities for acquisitions of rights to other novel technologies or solutions in the pharma or medical-related fields with significant unmet needs.

RVRC key facts

Ticker symbol

RVRC

Market tier

Pink

Sector

Healthcare

Industry

Health Information Services

Headquarters

Herzliya, Israel

Country of incorporation

US

Year of incorporation

1997

Employees

8

Estimated market cap

$30.36M (as of May 13, 2025)

Shares outstanding

60,729,100

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Revium Recovery Inc. leadership

• David Akunis — CEO
• Inna Martin — COO, President
• Arie Gordashnikov — CFO, Treasurer
• Eleanor Osmanoff — Counsel
• David Aboudi — Counsel

Explore more: Health Information Services stocks · Healthcare sector · Pink stocks · OTC stocks starting with R